Phase IV - Post Marketing Approval Trials

Phase IV studies are also called post marketing trials which are performed to further monitor side-effects of drug interactions that may not have been discovered in Phase III.  Many recently approved cancer drugs are entering Phase IV to satisfy the FDA requirements of surveillance.   Phase IV trials and continued drug safety monitoring are also known as pharmacovigilance studies